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1. Introduction 
The injection of oestradiol to the prepuberal or 
castrated rat results, 2-3 hr later, in a large increase 
in RNA biosynthesis [l] and in an increased ability 
of uterine nuclei to incorporate nucleoside triphos- 
phates into RNA [2]. Various reports have established 
that oestrogen-stimulated RNA is largely of ribosomal 
nature [3,4] . Recently, two different classes of DNA- 
dependent RNA polymerases have been solubilized 
and separated from rat liver and calf thymus [5,6] : 
one is of nucleolar origin (enzymes A or I) and insen- 
sitive to cwamanitin [lo] , the other is mainly nucleo- 
plasmic (enzymes B,, B,, or II) and inhibited by o-am- 
anitin [7, IO]. It has been shown that 2 hr after in- 
jection of oestradiol to immature female rats, the acti- 
vity of polymerase A, which is unaffected by cll-aman- 
itin, increases. This enzyme catalyses the synthesis of 
ribosomal-type RNA and may be assayed in a medium 
of low ionic strength [ 111. 
The administration of inhibitors of protein synthe- 
sis, such as puromycin or cycloheximide, just before 
or even immediately after oestradiol injection suppres- 
ses the increased RNA synthesis by low salt RNA poly- 
merase activity [12] . It thus appears that one of the 
earliest effects of oestradiol is to induce a “first-stage” 
protein synthesis, sufficiently slight to pass easily un- 
detected by conventional techniques during the “lag 
period” of the first hour, but of crucial importance 
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for the development of most, if not all, the subsequent 
aspects of oestradiol action including increased RNA 
synthesis observed after l-3 hr. Moreover, some ex- 
periments [ 131 seem to imply that continuous pro- 
tein synthesis is necessary to maintain the oestradiol- 
induced increase in RNA polymerase activity. On in- 
jection of rats with oestradiol and excision of the 
uterus 2-3 hr later, low salt RNA polymerase activity 
is found to have increased in the treated uteri as com- 
pared to the controls and a significant difference in 
activity may be maintained for 2 hr if the uteri are in- 
cubated at 37” in Eagle’s medium. Cycloheximide in 
the incubation medium suppresses that part of RNA 
polymerase activity due to oestradiol, thus implying 
that some activating protein(s) continue(s) to be syn- 
thesized in the surviving uteri. 
Since it appears that the oestrogen stimulation of 
RNA polymerase activity requires protein synthesis, 
it would be interesting to know whether or not this 
synthesis is promoted at the translational level. Ad- 
dition of Actinomycin D to the culture medium, in 
which the uteri are incubated in the experiments just 
mentioned above, would very likely inhibit RNA poly- 
merase activity in subsequently tested isolated nuclei, 
but it would not be possible to deduce whether this 
would be the consequence of inhibition of the end 
reaction (increased ribosomal RNA polymerase activ- 
ity) or whether an initial RNA synthesis catalysed by 
extranucleolar polymerase would be necessary for the 
synthesis of polymerase activity protein. However, the 
need for a “first stage” RNA synthesis can be estab- 
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Fig. 1. Nuclear RNA polymerase activity in oestradiol-primed 
(OII) and control (C) uteri. Incubation at 37” ; CHi: cyclo- 
heximide in the incubation medium. 
lished by the use of a specific inhibitor: the fungal 
polypeptide cu-amanitin which, however, does not 
block the secondarily increased polymerase activity. 
The effect of cw-amanitin, added during the incubation 
of uteri, on the RNA polymerase activity of isolated 
nuclei obtained either from control animals or animals 
treated with oestradiol, was therefore investigated. 
2. Methods 
Oestradiol(5 pg dissolved in 0.5 ml of a 0.9% NaC1, 5% 
ethanol solution) was administered subcutaneously to 
immature (20-23 day old) female Sprague Dawley 
rats. Control animals were injected with solvent only. 
Three hr after the injection, the animals were decapi- 
tated. Their uteri were excised and either assayed im- 
mediately for RNA polymerase activity (zero time on 
figures) or placed into flasks containing 2 ml of Eagle 
modified Dulbecco medium at 37”. Flasks, containing 
4 slit uterine horns each, were incubated in a shaking 
waterbath at 37” in an atmosphere of 95% O1 -5% 
COa for periods of time varying between O-2 hr. 
Where indicated, ar-amanitin (1 /.&ml: 1.2 PM) was 
added to the incubation medium. 
Following incubation, the uteri were homogenized. 
A nuclear preparation was obtained and the RNA poly- 
merase assayed [2]. The nuclear suspension from the 
uteri of each group was divided equally for 2-5 deter- 
minations. 0.3 ml of nuclear suspension, corresponding 
to approx. 200 pg of DNA, was incubated at 37” in 1 
Fig. 2. Nuclear RNA polymerase activity in oestradiol-primed 
(OII) and control (C) uteri. Incubation at 37” ; 4: or-amanitin 
in the incubation medium. 
ml of medium containing 3H-CTP, either with or 
without o-amanitin. Since the incorporation of 3H- 
CTP reaches a plateau after 10-l 5 min [14] ,20 min 
were chosen for single experimental points under the 
various conditions. After chilling, 1 ml of cold 10% 
HC104 was added. The contents of the tubes were 
centrifuged and the precipitate was washed 3 times 
with 5% HC104, twice with ethanol, then dried. The 
RNA was hydrolyzed with 0.3 N KOH for 1 hr at 
37’. The dpm incorporated per mg of RNA were de- 
termined as described previously [ 111. 
3. Results 
The activity of low salt DNA-dependent RNA 
polymerase in the rat uterus rises rapidly after in 
vivo treatment wtih oestradiol([2] , see figures : 
zero time ordinates). The oestradiol-stimulated in- 
crease in RNA synthesis in uterus nuclei prepared im- 
mediately after decapitation decreases ignificantly if 
the uteri have previously been incubated in Eagle’s 
medium. However, a difference in the level of the 
polymerase activity between the oestrogen-treated and 
control uteri is maintained for 2 hr if the surviving 
uteri have been incubated at 37” in tissue culture 
medium (solid lines on all figures). The addition of 
cycloheximide (25 pg/ml) to the incubation medium 
suppresses that part of RNA polymerase activity due 
to oestradiol. This result suggests that activating pro- 
tein is synthesized in the surviving uterine horns, and 
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Fig. 3. Nuclear RNA polymerase activity in oestradiol-primed 
(011) and control (C) uteri. Incubation at 37” ; cui: or-arnanitin 
in the incubation medium. 
confirms the results of Nicolette and Mueller [ 131. A 
dynamic study reveals that the increase due to oestrad- 
iol was suppressed already after 30 min (fig. 1, 011-vs- 
O,, t CHi), thus indicating that the apparent half-life 
of the protein is approximately 15 min under these 
conditions. 
The oestrogen-induced component of RNA poly- 
merase activity is furthermore very sensitive to the 
action of o-amanitin: 1 &ml of this agent in the tissue 
culture medium reduced within 1 hr the RNA poly- 
merase activity of surviving oestrogen-treated uteri to 
the level of that of the control uteri (fig. 2). On the 
other hand, the same concentration of o-amanitin in 
the culture medium has almost no effect on the poly- 
merase activity of control uteri. These experiments 
suggest hat the maintainance of the oestrogen-induced 
fraction of uterine polymerase activity requires the con- 
comitant synthesis of RNA. 
The very short half-life of RNA is illustrated in fig. 
3. Control and oestradiol-treated uteri are incubated 
for a very short time, 7 or 15 min in the culture med- 
ium with or without cr-amanitin. The presence of OL- 
amanitin in the incubation medium gives rise to marked 
inhibition : 70% of the oestradiol-induced increase in 
RNA polymerase activity within 15 min. 
To counteract the oestrogen stimulation, o-amanitin 
has to be present during the in vitro incubation of the 
surviving uteri, as it has no effect when added directly 
to the low salt nuclear system used to assay RNA poly- 
merase [ 111 . Indeed, a-amanitin has only a very limited 
0 min. 30 
Fig. 4. Nuclear RNA polymerase activity in oestradiol-primed 
(0~) and control (C) uteri. Incubation at 37” ; ori: a-amanitin 
in the incubation medium; oln: ol-amanitin during nuclear RNA 
polymerase assay. 
effect on the low-salt RNA polymerase activity of 
control nuclei or oestradiol-treated nuclei previously 
incubated in the culture medium (fig. 4). This con- 
firms, therefore, that the inhibition of the oestrogen- 
induced fraction of uterine polymerase activity by 
cu-amanitin occurs only when it is added to the incu- 
bation medium prior to the preparation of the nuclear 
fraction and RNA polymerase assay. 
4. Discussion 
Earlier studies have shown that cw-amanitin insensi- 
tive nucleolar RNA polymerase activity increases 2 hr 
after the injection of oestradiol to immature female 
rats [ 1 I] . On increasing the ionic strength of the nut-. 
lear RNA polymerase assay medium, this increase is 
suppressed, thus suggesting the presence of an oestrad- 
iol-induced component which activates o-amanitin re- 
sistant RNA synthesis, but is inactive in high salt med- 
ium. The component could be a new a-amanitin resis- 
tant polymerase or other factor, e.g. a protein inter- 
acting with a polymerase or some other component 
of the chromatin machinery involved in cr-amanitin 
resistant RNA synthesis, and unable to do so in a med- 
ium of high ionic strength [ I1 1. 
The present experiments indicate that the oestrad- 
iol-induced increase in low salt RNA polymerase ac- 
tivity is sensitive to protein synthesis inhibitors and to 
cr-amanitin. It thus appears that a protein activating 
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cr-amanitin insensitive polymerase activity may be 
formed which is itself dependent on a short-lived 
RNA synthesized by o-amanitin sensitive polymerase 
and therefore presumably mRNA. Another, and rather 
similar, inhibition of the synthesis of ribosomal RNA 
in rat liver nuclei follows the in vivo administration of 
cr-amanitin [ 151. One explanation for this could be 
that the action of the ribosomal RNA polymerase is 
regulated by some extranucleolar factor sensitive to 
cy-amanitin. 
It is thus possible that some type of RNA formed 
in the extranucleolar compartment exerts a regulatory 
effect over rRNA formation. Protein factors stimula- 
ting the activity of mammalian RNA polymerase have 
indeed been identified for extranucleolar polymerase 
B in calf thymus [ 161 and rat liver [ 171. It is there- 
fore quite conceivable that factors which stimulate 
nucleolar polymerase A activity might exist. 
The synthesis of such an activating protein which 
in turn stimulates cu-amanitin resistant, presumably 
nucleolar, RNA polymerase activity may be a decisive 
and possibly also limiting step in hormone action. 
Since no early increased synthesis of mRNA has been 
demonstrated for the various proteins involved in tis- 
sue growth, the increase in polymerase activity invol- 
ved in the synthesis of other RNAs (for example rRNA) 
could be a key mechanism in providing more protein 
synthesis by increased used of the mRNAs (for exam- 
ple, by increased processing transport, or translation). 
In this case, the activating protein would be a Key 
Intermediary Protein (KIP) which it would be very 
important to study. In vivo and in vitro experiments 
giving direct evidence for KIP and its‘potential mRNA 
are described elsewhere [ 18, 191. 
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